MedTrace Logo

Autoimmune Hepatitis Cohort in China

NCT05785793 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-03-28

No results posted yet for this study

Summary

The goal of this observational study is to describe the clinical features and long-term prognosis in patients diagnosed with autoimmune hepatitis (AIH) in China and assess the effectiveness and safety of AIH treatment options in a real-world setting.

Conditions

  • Autoimmune Hepatitis

Sponsors & Collaborators

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Xiong Ma, MD,PHD · Renji Hospital, School of Medicine, Shanghai Jiao Tong University

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2028-02-01
Completion
2028-02-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05785793 on ClinicalTrials.gov